Synthace
Biotechnology · Higher Education

Synthace: Ownership & structure

Sofinnova Crossover I Slp holds 25–50% of Synthace.

Data updated Nov 20, 2026 · Back to the company report

Owners & entities

Sofinnova Crossover I Slp holds 25–50% of Synthace.

Holders
Sofinnova Crossover I Slp
ownership of shares 25 to 50 percent; voting rights 25 to 50 percent · find-and-update.company-information.service.gov.uk ↗
25–50%
Legal entities1 in 1 country
operator · GB CRN 07652459
GB
Holders and shares as each register or filing states them.

Connections

Connections

List
Graph
Found in company registers, site code, DNS and hiring. Each connection shows how sure we are and the evidence, with its source and date.
Shared investors4
67 portfolio companies: Synthesia, Intract Pharma, Wellspring and 64 more
91 portfolio companies: Google DeepMind, Waze, Microsoft 2026 and 88 more
129 portfolio companies: IMIO, Alethio Therapeutics, Reyva and 126 more
198 portfolio companies: UKI2S, Microbial Solutions Seed, JustWye and 195 more
Show all 4